Researcher profile

Jang-Won Lee

Jang-Won Lee contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
8topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

High-Density Coding Scheme for SWIPT Systems

In this study, a novel coding scheme called highdensity coding based on high-density codebooks using a genetic local search algorithm is proposed. The high-density codebook maximizes the energy transfer capability by maximizing the ratio of 1 in the codebook while satisfying the conditions of a codeword with length n, a codebook with 2k codewords, and a minimum Hamming distance of the codebook of d. Furthermore, the proposed high-density codebook provides a trade-off between the throughput and harvested energy with respect to n, k, and d. The block error rate performances of the designed highdensity codebooks are derived theoretically and compared with the simulation results. The simulation results indicate that as d and k decrease, the throughput decreases by a maximum of 10% and 40%, whereas the harvested energy per time increases by a maximum of 40% and 100%, respectively. When n increases, the throughput decreases by a maximum of 30%, while the harvested energy per time increases by a maximum of 110%. With the proposed high-density coding scheme, the throughput and harvested energy at the user can be controlled adaptively according to the system requirements.

preprint2021arXiv

Low-complexity joint user and power scheduling in downlink NOMA over fading channels

Non-orthogonal multiple access (NOMA) has been considered one of the most promising radio access techniques for next-generation cellular networks. In this paper, we study the joint user and power scheduling for downlink NOMA over fading channels. Specifically, we focus on a stochastic optimization problem to maximize the weighted average sum rate while ensuring given minimum average data rates of users. To address this problem, we first develop an opportunistic user and power scheduling algorithm (OUPS) based on the duality and stochastic optimization theory. By OUPS, the stochastic problem is transformed into a series of deterministic ones for the instantaneous weighted sum rate maximization for each slot. Thus, we additionally develop a heuristic algorithm with very low computational complexity, called user selection and power allocation algorithm (USPA), for the instantaneous weighted sum rate maximization problem. Via simulation results, we demonstrate that USPA provides near-optimal performance with very low computational complexity, and OUPS well guarantees given minimum average data rates.

preprint2021arXiv

SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups

Phase I clinical trials are designed to test the safety (non-toxicity) of drugs and find the maximum tolerated dose (MTD). This task becomes significantly more challenging when multiple-drug dose-combinations (DC) are involved, due to the inherent conflict between the exponentially increasing DC candidates and the limited patient budget. This paper proposes a novel Bayesian design, SDF-Bayes, for finding the MTD for drug combinations in the presence of safety constraints. Rather than the conventional principle of escalating or de-escalating the current dose of one drug (perhaps alternating between drugs), SDF-Bayes proceeds by cautious optimism: it chooses the next DC that, on the basis of current information, is most likely to be the MTD (optimism), subject to the constraint that it only chooses DCs that have a high probability of being safe (caution). We also propose an extension, SDF-Bayes-AR, that accounts for patient heterogeneity and enables heterogeneous patient recruitment. Extensive experiments based on both synthetic and real-world datasets demonstrate the advantages of SDF-Bayes over state of the art DC trial designs in terms of accuracy and safety.